MEDICOX CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 548 KRW | -0.36% |
|
-7.12% | -50.41% |
| 05-14 | MEDICOX Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-20 | MEDICOX Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 81,852 | 44,677 | 77,230 | 92,623 | 83,711 | 35,784 |
| Enterprise Value (EV) 1 | 111,206 | 73,103 | 116,997 | 93,504 | 77,088 | 34,614 |
| P/E ratio | -41 x | -11.8 x | -7.12 x | -2.74 x | -1.67 x | -0.99 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 5.86 x | 2.02 x | 4.77 x | 5.31 x | 3.84 x | 1.33 x |
| EV / Revenue | 7.96 x | 3.31 x | 7.23 x | 5.36 x | 3.53 x | 1.29 x |
| EV / EBITDA | 292 x | -184 x | -39.5 x | -11.7 x | -6.75 x | -3.48 x |
| EV / FCF | -35.3 x | 94.5 x | -24.5 x | 95.1 x | -6.92 x | -2.25 x |
| FCF Yield | -2.83% | 1.06% | -4.08% | 1.05% | -14.5% | -44.4% |
| Price to Book | 4.55 x | 2.11 x | 2.04 x | 1.42 x | 1.36 x | 0.93 x |
| Nbr of stocks (in thousands) | 4,976 | 5,602 | 8,751 | 18,674 | 24,803 | 32,384 |
| Reference price 2 | 16,450 | 7,975 | 8,825 | 4,960 | 3,375 | 1,105 |
| Announcement Date | 27/09/19 | 28/02/20 | 09/03/21 | 21/03/22 | 21/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 13,971 | 22,103 | 16,190 | 17,449 | 21,817 | 26,875 |
| EBITDA 1 | 380.7 | -397 | -2,960 | -7,978 | -11,413 | -9,940 |
| EBIT 1 | -862.8 | -1,840 | -4,759 | -10,187 | -14,685 | -12,911 |
| Operating Margin | -6.18% | -8.33% | -29.4% | -58.38% | -67.31% | -48.04% |
| Earnings before Tax (EBT) 1 | -1,784 | -3,882 | -8,583 | -23,938 | -42,619 | -29,104 |
| Net income 1 | -1,784 | -3,595 | -8,583 | -23,935 | -42,619 | -32,378 |
| Net margin | -12.77% | -16.27% | -53.01% | -137.17% | -195.35% | -120.48% |
| EPS 2 | -401.2 | -675.7 | -1,240 | -1,808 | -2,018 | -1,117 |
| Free Cash Flow 1 | -3,150 | 773.9 | -4,770 | 983.5 | -11,144 | -15,363 |
| FCF margin | -22.54% | 3.5% | -29.46% | 5.64% | -51.08% | -57.16% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 27/09/19 | 28/02/20 | 09/03/21 | 21/03/22 | 21/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 29,354 | 28,425 | 39,767 | 882 | - | - |
| Net Cash position 1 | - | - | - | - | 6,624 | 1,170 |
| Leverage (Debt/EBITDA) | 77.1 x | -71.61 x | -13.44 x | -0.1105 x | - | - |
| Free Cash Flow 1 | -3,150 | 774 | -4,770 | 983 | -11,144 | -15,363 |
| ROE (net income / shareholders' equity) | -10% | -14% | -29.1% | -46% | -65.9% | -46.4% |
| ROA (Net income/ Total Assets) | -1% | -0.77% | -4.13% | -6.8% | -8.62% | -7.79% |
| Assets 1 | 178,206 | 466,678 | 207,807 | 352,185 | 494,353 | 415,549 |
| Book Value Per Share 2 | 3,617 | 3,778 | 4,331 | 3,499 | 2,476 | 1,191 |
| Cash Flow per Share 2 | 340.0 | 885.0 | 359.0 | 222.0 | 117.0 | 34.60 |
| Capex 1 | 257 | 260 | 1,418 | 1,563 | 3,700 | 448 |
| Capex / Sales | 1.84% | 1.18% | 8.76% | 8.96% | 16.96% | 1.67% |
| Announcement Date | 27/09/19 | 28/02/20 | 09/03/21 | 21/03/22 | 21/03/23 | 20/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -50.41% | 22.64M | |
| -0.23% | 8.26B | |
| -21.72% | 1.03B | |
| +27.89% | 755M | |
| +67.01% | 331M | |
| +47.00% | 277M | |
| +12.15% | 266M | |
| +29.77% | 113M | |
| +12.37% | 85.76M | |
| +2.41% | 80.25M |
- Stock Market
- Equities
- A054180 Stock
- Financials MEDICOX Co., Ltd.
